Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
Cyclerion Therapeutics, Inc. (CYCN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/09/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/04/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 11/09/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/27/2021 |
10-Q/A
| Quarterly Report for the period ended June 30, 2021 [amend] |
| 08/27/2021 |
10-Q/A
| Quarterly Report for the period ended March 31, 2021 [amend] |
| 07/29/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 04/30/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 07/31/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 05/04/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 11/12/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/12/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 05/13/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
|
|